Abstract:Objective To investigate the inhibition effect and mechanism of resveratrol on proliferation of gastric cancer MKN45 cell and the involvement of MEK/ERK signaling pathway. Methods Gastric cancer MKN45 cells were cultured according to the conventional signaling pathway method. The experiment was divided into control group, MEK/ERK signaling pathway inhibitor PD98059 group (20?mg/L, 100?μl), resveratrol low-dose group (100?μmol/L), resveratrol high-dose group (400?μmol/L). Gastric cancer MKN45 cell was treated with 1?h, 2?h and 4?h for subsequent follow-up. MTT assay was used to detect the cell viability of the inhibition rate of cell proliferation. Western blotting was used to analyze the expression of proteins such as Ras, Raf, MEK, ERK1/2. Immunocytochemistry was used to analyze the fluorescence intensity of Ras, Raf, MEK and ERK1/2. Results Compared with control group, the proliferation of cells in PD98059 group, low dose resveratrol group and high dose resveratrol group was significantly inhibited after treatment for 1?h, 2?h and 4?h with a time-dependent and dose-dependent way (P?0.05). Compared with the control group, the expressions of Ras, Raf, MEK and ERK1/2 was significantly decreased (P?0.05), and the difference was statistically significant. The effect of resveratrol has a dose-dependent effect (P?0.05). MEK and ERK1/2 proteins were also found to be mainly localized with immunofluorescence chemistry in the cytoplasm. And the fluorescence intensity of ERK1/2 in PD98059 group, low dose resveratrol group and high dose resveratrol group were significantly decreased. Conclusion Resveratrol has obvious inhibitory effect on proliferation of gastric cancer MKN45 cell with a dose-dependent way, and its mechanism may be related to the inhibition of the expression of Ras, Raf, MEK and ERK1/2 by inhibiting the MEK/ERK signaling pathway.